UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades

Harms, MH; Janssen, QP; Adam, R; Duvoux, C; Mirza, D; Hidalgo, E; Watson, C; ... European Liver and Intestine Transplant Association (ELITA); + view all (2018) Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Alimentary Pharmacology and Therapeutics , 49 (3) p. 285. 10.1111/apt.15060. Green open access

[thumbnail of Harms_et_al-2018-Alimentary_Pharmacology_%26_Therapeutics.pdf]
Preview
Text
Harms_et_al-2018-Alimentary_Pharmacology_%26_Therapeutics.pdf - Published Version

Download (621kB) | Preview

Abstract

BACKGROUND: The importance of primary biliary cholangitis as an indication for liver transplantation has probably been influenced by the introduction of therapies, and changes in selection criteria and disease epidemiology. AIMS: To assess the time trends in liver transplantation for primary biliary cholangitis and to evaluate the characteristics of the patient population during the past three decades. METHODS: Patients undergoing liver transplantation from 1986 to 2015 in centres reporting to the European Liver Transplantation Registry were included. We excluded combined organ transplantations and patients <18 years. Trends were assessed using linear regression models. RESULTS: We included 112 874 patients, of whom 6029 (5.3%) had primary biliary cholangitis. After an initial increase in the first decade, the annual number of liver transplantation for primary biliary cholangitis remained stable at around 200. The proportion of liver transplantations for primary biliary cholangitis decreased from 20% in 1986 to 4% in 2015 (P < 0.001). Primary biliary cholangitis was the only indication showing a consistent proportional decrease throughout all decades. From the first to the third decade, the age at liver transplantation increased from 54 (IQR 47-59) to 56 years (IQR 48-62) and the proportion of males increased from 11% to 15% (both P < 0.001). CONCLUSIONS: We have found a proportional decrease in primary biliary cholangitis as indication for liver transplantation. However, despite treatment with ursodeoxycholic acid and improved disease awareness, the absolute annual number of liver transplantations has stabilised.

Type: Article
Title: Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/apt.15060
Publisher version: http://doi.org/10.1111/apt.15060
Language: English
Additional information: Copyright © 2018 The Authors. Alimentary Pharmacology & Therapeutics Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. © 2018 The Authors. Alimentary Pharmacology & Therapeutics Published by John Wiley & Sons Ltd.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inst for Liver and Digestive Hlth
URI: https://discovery.ucl.ac.uk/id/eprint/10065067
Downloads since deposit
74Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item